European Heart Journal Advance Access published online on February 27, 2008
European Heart Journal, doi:10.1093/eurheartj/ehn060
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus: eluting and bare metal stents
1 Cardiology Department, Heraklion University Hospital, PO Box 1352, Heraklion 71110, Crete, Greece
2 Laboratory of Virology, University of Crete, Crete, Greece
3 Division of Biostatistics, University of Crete, Crete, Greece
Received 6 October 2007; revised 16 January 2008; accepted 24 January 2008.
* Corresponding author. Tel: +30 2810 392877. Email: cardio{at}med.uoc.gr
Aims: Although previous studies have indicated that vascular endothelial growth factor (VEGF) plays an important role in the vascular-healing process after stent implantation, its effect on in-stent restenosis is unclear. We assessed VEGF serum protein levels and gene expression in peripheral monocytes in relation to in-stent restenosis after implantation of sirolimus-eluting (SES) and bare metal stents (BMS) in a non-blinded, randomized study.
Methods and results: Forty-two patients (28 men, age 62 ± 11 years) with stable angina, who underwent elective single-vessel percutaneous coronary intervention, were randomized to SES (n = 21) or BMS (n = 21) implantation. VEGF protein levels in the BMS group showed an increasing trend (P = 0.083), whereas in the SES group they decreased significantly (P = 0.002). BMS induced up-regulation of VEGF mRNA levels, whereas for SES down-regulation was observed. There was no correlation between serum levels and late luminal loss. A significant correlation was found between VEGF gene expression and late luminal loss in both groups (BMS: r = 0.98, P < 0.001; SES: r = 0.65, P = 0.002).
Conclusion: SES, in comparison with BMS, results in lower VEGF protein levels and gene expression in peripheral monocytes. The latter shows a positive relationship with in-stent late-luminal loss, suggesting an essential role in the reduced in-stent restenosis seen in SES.
Key Words: Vascular endothelial growth factor Sirolimus-eluting stents Restenosis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
F. S. Czepluch and J. Waltenberger Vascular endothelial growth factor protein levels and gene expression in peripheral monocytes after stenting: a randomized comparative study of sirolimus-eluting and bare-metal stents Eur. Heart J., August 1, 2008; 29(15): 1924 - 1925. [Full Text] [PDF] |
||||
